Home » Topics » Regulatory

Regulatory
RSS

Topical formulation of Targretin launched in U.S. for CTCL therapy

Sep. 28, 2000

No Comments

Simdax approved in Sweden for severe heart failure

Sep. 28, 2000

No Comments

Combinations with synergistic antitumor activity claimed by Pharmacia

Sep. 27, 2000

No Comments

FDA approves Trisenox for APL only three years after U.S. studies began

Sep. 27, 2000

No Comments

Levaquin tablets/injection approved for new indication in U.S.

Sep. 22, 2000

No Comments

Once-daily tramadol enters phase III

Sep. 21, 2000

No Comments

FDA approves QVAR Inhalation Aerosol for treatment of asthma

Sep. 20, 2000

No Comments

New formulation of Zyprexa introduced for psychotic disorders and manic episodes

Sep. 20, 2000

No Comments

Glaxo Wellcome seeks new indication for Relenza

Sep. 19, 2000

No Comments

New HIV treatment option approved by FDA

Sep. 19, 2000

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Regulatory
RSS

Topical formulation of Targretin launched in U.S. for CTCL therapy

Simdax approved in Sweden for severe heart failure

Combinations with synergistic antitumor activity claimed by Pharmacia

FDA approves Trisenox for APL only three years after U.S. studies began

Levaquin tablets/injection approved for new indication in U.S.

Once-daily tramadol enters phase III

FDA approves QVAR Inhalation Aerosol for treatment of asthma

New formulation of Zyprexa introduced for psychotic disorders and manic episodes

Glaxo Wellcome seeks new indication for Relenza

New HIV treatment option approved by FDA

Today's news in brief

Today's news in brief

Caplyta star shines as J&J takes Intra-Cellular in $14.6B deal

Proteomics study explores how protein changes influence disease

Abbvie and Simcere enter a $1B T-cell engager deal

Regulatory RSS

Regulatory
RSS